During the past decade, Inova Heart and Vascular Institute conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 15 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 11 clinical trials were completed. i.e. 137.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inova Heart and Vascular Institute" #1 sponsor was "Actelion" with 5 trials, followed by "Inova Health Care Services" with 5 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 3 trials sponsored, "HeartStitch.Com" with 2 trials sponsored and "STAVROS G DRAKOS" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inova Heart and Vascular Institute" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "AcitGraph" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Inova Heart and Vascular Institute" are "Coronary Artery Disease" (4 trials), "Heart Failure" (4 trials), "Idiopathic Pulmonary Fibrosis" (3 trials), "Mitral Valve Insufficiency" (3 trials) and "Pulmonary Hypertension" (3 trials). Many other conditions were trialed in "Inova Heart and Vascular Institute" in a lesser frequency.

Most popular intervention types in "Inova Heart and Vascular Institute" are "Drug" (13 trials), "Device" (9 trials), "Other" (6 trials), "Procedure" (4 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Bosentan" (2 trials), "CABG" (2 trials), "Oral treprostinil" (2 trials) and "ASV Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inova Heart and Vascular Institute" are 35 trials for "All" genders.

Currently, there are 9 active trials in "Inova Heart and Vascular Institute". 1 are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Inova Heart and Vascular Institute, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Inova Heart and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".